Perchlorate

Perchlorate

SCHEMBL7250930

CC[n+]1c(C)oc2ccc3ccccc3c21.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ APEX1 P27695 1/20 0.41
▸ CTNNB1 P35222 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HNF4A P41235 3/20 0.37
▸ HK1 P19367 1/20 0.35
▸ RAD52 P43351 1/20 0.35
▸ HKDC1 Q2TB90 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021802 0.94 KDM4E (0.41) KDM4ERAB9AMAPTNPC1TDP1
Iodide SCHEMBL5892501 0.76 KDM4E (0.43) KDM4ERAB9AMAPTNPC1TDP1
SCHEMBL7254059 0.74 KDM4E (0.53) KDM4ERAB9AMAPTNPC1TDP1
Perchlorate SCHEMBL7256390 0.71 KDM4E (0.50) KDM4ERAB9AMAPTNPC1TDP1
SCHEMBL8385263 0.69 KDM4E (0.50) KDM4ERAB9AMAPTNPC1TDP1
SCHEMBL25672214 0.68 CYP2A6 (0.39) KDM4ERAB9ATDP1MEN1KMT2A
SCHEMBL4626775 0.66 — —
SCHEMBL1046351 0.64 MEN1 (0.48) KDM4ERAB9AMAPTNPC1TDP1
SCHEMBL4830357 0.64 KDM4E (0.55) KDM4ERAB9AMAPTTDP1MEN1
Iodide SCHEMBL1776694 0.63 MEN1 (0.50) KDM4ERAB9AMAPTNPC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6635090-B1 Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative L'OREAL, S.A. (FR) 2003-10-21 — — US claimed
Send feedback